NASDAQ : KMDA
Kamada Ltd. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · Israel
Last price 7.95 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 451.69M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 422.62M |
| Enterprise Value | 367.29M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | Aug 27, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 57.71M |
| Shares Outstanding | 57.89M |
| Shares Change (YoY) | -1.60% |
| Shares Change (QoQ) | -1.93% |
| Owned by Insiders (%) | 4.41% |
| Owned by Institutions (%) | 16.81% |
| Float | 33.08M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 20.37 |
| Forward PE | 16.09 |
| PS Ratio | 2.20 |
| Forward PS | 2.02 |
| PB Ratio | 1.57 |
| P/TBV Ratio | 2.91 |
| P/FCF Ratio | 16.06 |
| P/OCF Ratio | 11.82 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 16.51 |
| EV / Sales | 1.91 |
| EV / EBITDA | 8.85 |
| EV / EBIT | 13.20 |
| EV / FCF | 13.96 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.06 |
| Quick Ratio | 2.29 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.27 |
| Debt / FCF | 0.45 |
| Interest Coverage | 26.79 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 8.40% |
| Return on Assets (ROA) | 4.63% |
| Return on Invested Capital (ROIC) | 11.35% |
| Return on Capital Employed (ROCE) | 8.33% |
| Weighted Average Cost of Capital (WACC) | 5.04% |
| Revenue Per Employee | $415,258 |
| Profits Per Employee | $48,165 |
| Employee Count | 462 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 1.34 |
Taxes
| Measure | Value |
|---|
| Income Tax | 4.43M |
| Effective Tax Rate | 16.60% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.13 |
| 52-Week Price Change | +6.36% |
| 50-Day Moving Average | 8.18 |
| 200-Day Moving Average | 8.02 |
| Relative Strength Index (RSI) | 36.19 |
| Average Volume (20 Days) | 74,932 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 197,486 |
| Short Previous Month | 209,476 |
| Short % of Shares Out | 0.63% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.96 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 191.85M |
| Gross Profit | 78.31M |
| Operating Income | 27.83M |
| Pretax Income | 26.68M |
| Net Income | 22.25M |
| EBITDA | 41.49M |
| EBIT | 27.83M |
| Earnings Per Share (EPS) | $0.36 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 70.13M |
| Total Debt | 11.80M |
| Net Cash | 58.33M |
| Net Cash Per Share | $1.01 |
| Equity (Book Value) | 269.56M |
| Book Value Per Share | 4.66 |
| Working Capital | 150.42M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 35.76M |
| Capital Expenditures | -9.44M |
| Depreciation & Amortization | 13.66M |
| Net Borrowing | -1.41M |
| Free Cash Flow | 26.32M |
| FCF Per Share | $0.45 |
Margins
| Measure | Value |
|---|
| Gross Margin | 40.82% |
| Operating Margin | 14.51% |
| Pretax Margin | 13.91% |
| Profit Margin | 11.60% |
| EBITDA Margin | 21.63% |
| EBIT Margin | 14.51% |
| FCF Margin | 13.72% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.42 |
| Dividend Yield | 5.71% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 116.38% |
| FCF Payout Ratio | 92.39% |
| Buyback Yield | 1.60% |
| Shareholder Yield | 7.31% |
| Earnings Yield | 4.91% |
| FCF Yield | 6.23% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $13.50 |
| Price Target Difference | 83.42% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 10.30% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.47 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |